We have described previously a novel Ca 2ϩ -induced Ca 2ϩ -release (CICR) mechanism in permeabilized A7r5 cells (embryonic rat aorta) and 16HBE14o-cells (human bronchial mucosa) cells (J Biol Chem 278: 27548 -27555, 2003). This CICR mechanism was activated upon the elevation of the free cytosolic calcium concentration [Ca 2ϩ ] c and was not inhibited by pharmacological inhibitors of the inositol-1,4,5-trisphosphate (IP 3 ) receptor nor of the ryanodine receptor. This CICR mechanism was inhibited by calmodulin (CaM) 1234 , a Ca 2ϩ -insensitive CaM mutant, and by different members of the superfamily of CaMlike Ca 2ϩ -binding proteins. Here, we present evidence that the CICR mechanism that is expressed in A7r5 and 16HBE14o-cells is strongly activated by suramin and 4,4Ј-diisothiocyanatostilbene-2,2Ј-disulfonic acid (DIDS). We found several indications that both activation mechanisms are indeed two different modes of the same release system. Suramin/DIDS-induced Ca 2ϩ release was only detected in cells that displayed the CICR mechanism, and cell types that do not express this type of CICR mechanism did not exhibit suramin/DIDS-induced Ca 2ϩ release. Furthermore, we show that the suramin-stimulated Ca 2ϩ release is regulated by Ca 2ϩ and CaM in a similar way as the previously described CICR mechanism. The pharmacological characterization of the suramin/DIDS-induced Ca 2ϩ release further confirms its properties as a novel CaM-regulated Ca 2ϩ -release mechanism. We also investigated the effects of disulfonated stilbene derivatives on IP 3 -induced Ca 2ϩ release and found, in contrast to the effect on CICR, a strong inhibition by DIDS and 4Ј-acetoamido-4Ј-isothiocyanostilbene-2Ј,2Ј-disulfonic acid.
release. Furthermore, we show that the suramin-stimulated Ca 2ϩ release is regulated by Ca 2ϩ and CaM in a similar way as the previously described CICR mechanism. The pharmacological characterization of the suramin/DIDS-induced Ca 2ϩ release further confirms its properties as a novel CaM-regulated Ca 2ϩ -release mechanism. We also investigated the effects of disulfonated stilbene derivatives on IP 3 -induced Ca 2ϩ release and found, in contrast to the effect on CICR, a strong inhibition by DIDS and 4Ј-acetoamido-4Ј-isothiocyanostilbene-2Ј,2Ј-disulfonic acid.
Changes in cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] c ) mediate a variety of cellular processes, ranging from fertilization to cell death. The endoplasmic reticulum (ER) and sarcoplasmic reticulum (SR) serve as the main sources of releasable Ca 2ϩ for cytosolic cellular signaling. Calcium pumps of the sarco(endo)-plasmic-reticulum Ca 2ϩ -ATPase family import Ca 2ϩ into the organelle lumen. Two families of intracellular Ca 2ϩ -release channels are primarily responsible for the release, the inositol-1,4,5-trisphosphate receptor (IP 3 R) and the ryanodine receptor (RyR) (Berridge et al., 2003) .
Recent studies have emphasized the role of novel types of intracellular Ca 2ϩ -release channels possibly playing an important role in intracellular Ca 2ϩ signaling. Wissing et al. (2002) identified a novel Ca 2ϩ -induced Ca 2ϩ -release (CICR) mechanism in permeabilized hepatocytes that responded to modest increases in [Ca 2ϩ ] c . A CICR atypical of the SR type was found in mouse pancreatic ␤-cells (Beauvois et al., 2004) . Polycystin-2, the product of the gene mutated in type-2 autosomal dominant polycystic kidney disease and a prototypical member of a subfamily of the transient receptor potential channel superfamily (TRP), is expressed abundantly in the ER. It was shown recently that polycystin-2 expressed in the ER of epithelial cells is a Ca 2ϩ -activated channel that is permeable for divalent cations. Increased levels of intracellular Ca 2ϩ activated polycystin-2-mediated release of Ca 2ϩ from intracellular stores (Koulen et al., 2002) . Moreover, there are indications that some bona fide plasmalemmal Ca 2ϩ -permeable TRP channels (e.g., TRPV1 and TRPM8) also reside in intracellular membranes where they may function as Ca 2ϩ -release channels (Turner et al., 2003; Zhang and Barritt, 2004) . In a previous study, we described a novel CICR mechanism in permeabilized A7r5 cells, a permanent cell line derived from embryonic rat aorta (Nadif Kasri et al., 2003) . This CICR mechanism was activated upon the elevation of the [Ca 2ϩ ] c and was not inhibited by pharmacological inhibition of the IP 3 R or of the RyR. Moreover, we found that this CICR mechanism could be inhibited by CaM 1234 , a Ca 2ϩ -insensitive CaM mutant, and by different members of the superfamily of CaM-like Ca 2ϩ -binding proteins. Our data suggested that the CICR mechanism described here may represent a novel type of Ca 2ϩ -release channel, which is silent at low [Ca 2ϩ ] c because of inhibition by bound apocalmodulin and which becomes activated by the Ca 2ϩ -dependent interaction with CaM.
Suramin and disulfonic stilbene derivatives have been extensively used as pharmacological probes to study the transport kinetics and molecular structures of a wide range of membrane transporters. An excellent example of this includes the structure of the ATP-binding site of the sarco(endo)plasmic-reticulum Ca 2ϩ -ATPase (Hua and Inesi, 1997) . 4,4Ј-Diisothiocyanatostilbene-2,2Ј-disulfonic acid (DIDS) has been widely used to understand the role and mechanism of various ion transport processes in the muscle sarcolemma and the SR (Cabantchik and Greger, 1992) . 4Ј-acetoamido-4Ј-isothiocyanostilbene-2Ј,2Ј-disulfonic acid (SITS) is commonly used for the study of anion transporters, and like DIDS it possesses structural similarities to suramin. Suramin (1,3,5-naphthylenetrisulfonic acid) is a trypanoside that acts as an ATP antagonist for P2-purinoceptors (Hoyle et al., 1990) . On the RyR it acts as a strong activator, and regulates the RyR via a binding site that is distinct from its adenine nucleotide binding site (Emmick et al., 1994) . Suramin has also been postulated to act on the RyR via binding to the CaM-binding site (Klinger et al., 1999) . Suramin was found to bind directly to CaM-binding sites on the RyR and the IP 3 R (Klinger et al., 1999; Nadif Kasri et al., 2004) . Although suramin and disulfonic stilbene derivatives have been extensively used to study the RyR, data on the effects on IP 3 Rs or IP 3 -induced Ca 2ϩ release (IICR) are scarce. Previous results, however, have shown that endogenous sulfonate derivatives can regulate IP 3 R function (Watras et al., 2000) . In this study, therefore, we have used suramin and stilbene derivatives to further characterize the previously detected CICR mechanism, and we also investigated the effects of these compounds on IICR.
In a first part, we present evidence that the CICR mechanism that is expressed in A7r5 and 16HBE14o-cells is strongly activated by suramin and DIDS. Other cell types that do not express this type of CICR mechanism did not exhibit any suramin/DIDS-induced Ca 2ϩ release. Furthermore, we show that this suramin-stimulated Ca 2ϩ release is regulated in a similar way as the previously described CICR mechanism (Nadif Kasri et al., 2003) . The pharmacological characterization further confirms the properties of this CICR mechanism as a novel CaM-regulated Ca 2ϩ -release mechanism. We also investigated the effects on IICR and found, in contrast to the effect on CICR, a strong inhibition by DIDS and SITS.
Materials and Methods
Materials. Suramin was purchased from Sigma-Aldrich (Bornem, Belgium). DIDS, SITS, and 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid (DNDS) were purchased from Molecular Probes (Leiden, The Netherlands).
45 Ca 2؉ Fluxes. A7r5 cells, which are derived from embryonic rat aorta smooth muscle cells, were obtained from the American Type Culture Collection (Manassas, VA) (CRL 1444). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 3.8 mM L-glutamine, 0.9% (v/v) nonessential amino acids, 85 IU/ml penicillin, 85 g/ml streptomycin, and 20 mM HEPES, pH 7.4. For 16HBE14o-(human bronchial mucosa) cells, a mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium was used, and for LLC-PK 1 cells minimal essential medium-␣ was used. L15 cells were obtained by stable exogenous expression of IP 3 R1 in Lvec cells, whereas Lvec cells represent the control cells expressing the empty vector (Miyawaki et al., 1990; Mackrill et al., 1996) . 45 Ca 2ϩ fluxes were performed on saponin-permeabilized cells. The cells were seeded in 12-well clusters (Costar, Cambridge, MA) at a density of approximately 4 ϫ 10 4 cm
Ϫ2
. Experiments were carried out on confluent monolayers of cells (3 ϫ 10 5 cells/well) between the seventh and ninth day after plating. Cells were permeabilized by incubating them for 10 min with a solution containing 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, 2 mM MgCl 2 , 1 mM ATP, 1 mM EGTA, and 20 g/ml saponin at 25°C. The nonmitochondrial Ca 2ϩ stores were loaded for 45 min at 25°C in 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, 5 mM MgCl 2 , 5 mM ATP, 0.44 mM EGTA, 10 mM NaN 3 , and 150 nM free 45 Ca 2ϩ (28 Ci/ml). The cells were then washed twice with 1 ml of efflux medium containing 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, 1 mM EGTA, and 10 M thapsigargin (TG). TG was added to block the ER Ca 2ϩ pumps during subsequent additions of Ca 2ϩ . The efflux medium was replaced every 2 min, and the efflux was performed at 25°C. The additions of 40 Ca 2ϩ , IP 3 , suramin, and stilbene derivatives are indicated on the figures (arrow). Free [Ca 2ϩ ] was calculated by the Cabuf program (ftp://ftp. cc.kuleuven.ac.be/pub/droogmans/cabuf.zip) and based on the stability constants as published previously (Fabiato and Fabiato, 1979) . At the end of the experiment, the 45 Ca 2ϩ remaining in the stores was released by incubation with 1 ml of a 2% sodium dodecyl sulfate solution for 30 min. Ca 2ϩ release in some experiments is plotted as the fractional loss (i.e., the amount of Ca 2ϩ released in 2 min divided by the total store Ca 2ϩ content at that time). The latter value was calculated by summing in retrograde order the amount of tracer remaining in the cells at the end of the efflux and the amounts of tracer collected during the successive time intervals.
CaM-Sepharose Pull-Down Assay. CaM-Sepharose 4B (50 l) (Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK) was incubated with 500 ng of recombinant IP 3 R1 purified from Sf9 cells for 2 h at 4°C in incubation buffer [i.e., one part Trisbuffered saline (20 mM Tris-HCl, pH 7.2, and 150 mM NaCl) mixed with one part bacterial ProFound lysis buffer containing a Trisbuffered solution of 75 mM NaCl with 1% of a nonionic detergent (according to the manufacturer's protocol; Pierce Chemical, Rockford, IL), and supplemented with 1 mM ␤-mercaptoethanol]. Unbound protein was removed by washing the Sepharose beads four times with 500 l of the incubation buffer. Bound IP 3 R1 protein was eluted by incubating the beads with LDS (Invitrogen, Carlsbad, CA) for 10 min at 70°C, and the beads were removed by centrifugation at 20,000g for 1 min. All samples were separated on NuPAGE 3 to 8% Tris-acetate SDS-polyacrylamide gel electrophoresis gels and analyzed by Western blotting, using a rabbit polyclonal antibody against IP 3 R1 (Rbt03) as the primary antibody (Parys et al., 1995) [ 3 H]IP 3 -Binding Experiments. Binding studies were performed as described previously. 
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EGTA, 10 mM ␤-mercaptoethanol, and 10 nM [ 3 H]IP 3 . Nonspecific binding was determined in the presence of 12.5 M unlabeled IP 3 . After 30 min of incubation, the samples were rapidly filtered through glass-fiber filters. The amount of Sf9 microsomes expressing IP 3 R1 ranged between 100 and 150 g. Statistical analysis was performed using the paired Student's t test. Values were considered significantly different when P Ͻ 0.05.
Expression and Purification of Recombinant Proteins. Recombinant CaM and CaM 1234 were expressed and purified as described previously (Sienaert et al., 2002) .
Expression and Purification of IP 3 R1 from Sf9 Cells. Production of recombinant viruses, expression and purification of recombinant IP 3 R1 proteins in Sf9 insect cells, and preparation of the microsomes were as described previously (Sipma et al., 1999; Vermassen et al., 2004) .
Results

Suramin Stimulates Ca
2؉ Release from Intracellular Stores. In A7r5 cells, Ca 2ϩ release from intracellular stores, mainly from the ER, occurs to a large extent via production of the second messenger IP 3 . In the permeabilized cell system, a maximal effective dose of IP 3 (100 M) can release up to 95% of the intracellular Ca 2ϩ content (Missiaen et al., 1990) . We previously identified a CICR mechanism that contributed significantly to the Ca 2ϩ release from the ER (40%) (Nadif Kasri et al., 2003) . This CICR mechanism was found to be highly regulated by CaM. Because suramin has already been used extensively to study intracellular Ca 2ϩ -release channels and has been reported to bind directly on CaM-binding sites (Klinger et al., 1999 (Klinger et al., , 2001 , we tested the effects of suramin on intracellular Ca 2ϩ release in A7r5 cells. The nonmitochondrial stores of permeabilized A7r5 cells were loaded to steady state with 45 Ca 2ϩ and then incubated in a nonlabeled efflux medium containing 10 M thapsigargin.
The loss of Ca 2ϩ from the stores under these conditions is plotted as ER Ca 2ϩ content as a function of time (Fig. 1A) . After 10 min of efflux, the cells were challenged with 100 M suramin during 2 min, as indicated by the arrow. Suramin (100 M) strongly increased the rate of Ca 2ϩ release (Fig.  1A) . In these conditions, the amount of the stored Ca 2ϩ that could be released by suramin was 33% (Fig. 1B) . The total amount of releasable Ca 2ϩ was measured by treating the cells with 5 M ionophore A23187 (triangles). A dose-response curve is shown in Fig. 1B . Suramin stimulated Ca 2ϩ release from the intracellular stores with an EC 50 of 93 Ϯ 9 M, and the activation curve had a Hill coefficient of 1.0 Ϯ 0.1. A saturating concentration of suramin was found to release up to 70% of the stored Ca 2ϩ in A7r5 cells. Suramin-Induced Ca 2؉ Release Is Expressed in the Same Cell Types as the CICR Mechanism. Next, we investigated whether this suramin-induced Ca 2ϩ release could be observed in other cell types that express the CICR mechanism described previously in A7r5 cells. Therefore, we performed the same experiments in 16HBE14o-cells, in which a similar CICR mechanism is expressed, and in COS-1, LLC-PK 1 , L15, and Lvec cells, in which we could not detect this mechanism (Nadif Kasri et al., 2003) . Suramininduced Ca 2ϩ release was only observed in 16HBE14o-cells and not in the other cell types (Fig. 2) . Suramin maximally released 40% of the stored Ca 2ϩ with an EC 50 of 104 Ϯ 8 M in 16HBE14o-cells, which is identical to that observed in A7r5 cells. These data indicate that the Ca 2ϩ release induced by suramin is not a property of all cells and is therefore not caused by a nonspecific leak. Hence, these data suggest that suramin-induced Ca 2ϩ release is a property of cells that express the previously described CICR mechanism. 
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Suramin-Induced Ca 2؉ Release Is Neither IP 3 R-nor RyR-Mediated. The two major classes of intracellular Ca 2ϩ -release channels are the IP 3 Rs and the RyRs. In A7r5 cells, only IP 3 R1 (73%) and IP 3 R3 (26%) are expressed (De Smedt et al., 1994) . No evidence has been found for a functional activity of the RyR in A7r5 cells, as there was no measurable Ca 2ϩ release by caffeine or cyclic ADP-ribose (Missiaen et al., 1990) .
Because suramin was shown to potently activate several types of ion channels (Hill et al., 2004 , and references therein), we wanted to investigate the possibility that suramin acted directly on the IP 3 R. Heparin and xestospongin C (XeC) are often used as antagonists of the IP 3 R. In Fig.  3A , we show that these compounds did not affect the fractional loss induced by 100 M suramin, strongly suggesting that the IP 3 R was not involved in this mechanism. Although there is no evidence for a functional RyR in A7r5 cells, we also used an antagonist of the RyR to exclude any role of the RyR in this suramin-induced Ca 2ϩ release. Figure 3B illustrates that 100 M ruthenium red (RuRed) had no effect on the fractional loss induced by 100 M suramin. Ca 2ϩ release stimulated by sphingosine-1-phosphate (S1P) (Pyne and Pyne, 2000) and NAADP (Genazzani and Galione, 1996) has been observed in a number of cell types. However, it is unlikely that one of these mechanisms is activated by suramin in A7r5 cells because no S1P-or NAADP-stimulated Ca 2ϩ release was observed in A7r5 cells under our assay conditions (data not shown).
Characteristics of the Observed Suramin-Induced Ca 2؉ Release. Fig. 4A released by suramin from fully loaded stores was higher than the release from less filled stores. The Ca 2ϩ content of the cells induced by suramin after 2 min was depleted more extensively than the Ca 2ϩ content of cells that were induced after 20 min. These results indicate that the suramin-induced Ca 2ϩ release was controlled by the luminal [Ca 2ϩ ]. In this respect, the suramin-induced Ca 2ϩ release shows the same dependence on the luminal Ca 2ϩ content as described for both the CICR (Nadif Kasri et al., 2003) or for the IICR mechanism in those cells (Missiaen et al., 1992) .
We have shown previously that the CICR mechanism in A7r5 cells originated from the IP 3 -sensitive and TG-sensitive stores. We investigated whether the suramin-induced Ca 2ϩ release described here was originating from the same IP 3 -and TG-sensitive stores. (Fig. 4C) . This Ca 2ϩ dependence had a similar EC 50 as that previously measured for activation of the CICR mechanism (700 nM free Ca 2ϩ ) (Nadif Kasri et al., 2003) . We also observed that suramininduced Ca 2ϩ release and CICR were only partially additive. This could suggest that suramin and Ca 2ϩ activate the same mechanism and that Ca 2ϩ is also a modulator of the suramin-induced Ca 2ϩ release. In contrast to the CICR mechanism, Ca 2ϩ release induced by suramin was not potentiated by ATP (data not shown). Suramin was identified previously as an ATP antagonist for P2-purinoceptors and RyRs (Hoyle et al., 1990; Mallard et al., 1992; Emmick et al., 1994) . Therefore, we can hypothesize that the lack of activation by ATP could be explained by binding of suramin to a ATP-binding site.
An important characteristic of CICR described previously was the role of CaM as a Ca 2ϩ sensor (Nadif Kasri et al., 2003) . We showed that when cells were incubated with CaM 1234 , CICR was completely blocked. Further characterization revealed that CaM acted as a Ca 2ϩ sensor for this CICR mechanism and that CaM 1234 had dominant negative properties. Assuming that suramin activates the same CICR mechanism, CaM 1234 should also block suramin-induced Ca 2ϩ release. Indeed, when 10 M CaM 1234 was added to permeabilized cells, suramin-induced Ca 2ϩ release was nearly completely inhibited (89 Ϯ 4%). This was not the case when CaM itself was added (Fig. 5) . Thus, suramin-induced Ca 2ϩ release shows remarkable similarities with the CICR mechanism in A7r5 cells with respect to the Ca 2ϩ and CaM dependence. Suramin-induced Ca 2ϩ release, however, does also occur in the complete absence of Ca 2ϩ (EGTA), which suggests that suramin is an independent activator and not merely a regulator of the CICR mechanism. 
Stilbene Derivatives Induce Ca 2؉ Release in A7r5 Cells. DIDS and SITS (Fig. 6A) are normally regarded as chemical probes for the study of anion transporters. However, because they possess structural similarities to suramin, they have also been used as a ligand for purinoceptors and RyRs. We have tested the effects of those derivatives on intracellular Ca 2ϩ release in A7r5 cells. When applied to permeabilized cells, 100 M DIDS induced a Ca 2ϩ release (18 Ϯ 3%) comparable with the activation of suramin, whereas SITS and DNDS were not effective (Fig. 6B) . A dose-response curve of the activation by DIDS revealed that the EC 50 for DIDS activation was higher than for suramin (Fig. 6C) . Similar to the suramin-induced Ca 2ϩ release, CaM 1234 inhibited Ca 2ϩ release induced by DIDS by 83 Ϯ 3% (data not shown), suggesting that both suramin and DIDS activate the same Ca 2ϩ -release mechanism. Stilbene Derivatives Inhibit IICR. Although stilbene derivatives have been extensively used to study several types of ion channels, no data are available for IP 3 Rs. We have therefore investigated the effects of DIDS, SITS, and DNDS on IICR. To prevent any interference with the previously described suramin/DIDS-induced Ca 2ϩ -release mechanism, we used permeabilized L15 and Lvec fibroblast cells, which do not express CICR and in which suramin did not promote Ca 2ϩ release (Fig. 2) . Western blots indicated a 3:1 ratio for IP 3 R1/IP 3 R3 for L15 and the reverse ratio for Lvec cells (data not shown). This comparison was made because differences between both IP 3 R isoforms may yield different results, as was shown for RyR isoforms (Sitsapesan, 1999; O'Neill et al., 2003; Hill et al., 2004) .
In permeabilized L15 or Lvec cells, the addition of 200 nM IP 3 to the efflux medium induced Ca 2ϩ release from the nonmitochondrial internal stores. IICR was inhibited in a concentration-dependent way by both DIDS and SITS, whereas DNDS did not have any effect. Because the inhibition occurred to the same extent in both cell lines, it can be concluded that these effects are not isoform specific. Doseresponse curves for DIDS and SITS inhibition in L15 cells are presented in Fig. 7A . With 200 nM IP 3 in L15 cells, DIDS half-maximally inhibited IICR at a concentration of 0.7 Ϯ 0.02 M and SITS at a concentration of 9.3 Ϯ 0.47 M.
As indicated in Fig. 7B , the blocking effect of DIDS or SITS was essentially irreversible. Permeabilized L15 cells were preincubated with 100 M DIDS or SITS for 6 min followed by a washout period of 4 min before activation with 200 nM IP 3 . The decrease of IICR was compared with cells that were incubated with 100 M DIDS or SITS for 12 min with no washout period before activation with 200 nM IP 3 . Cells that were treated for 6 min showed a similar decrease in IICR compared with cells that were incubated for 12 min. DIDS completely inhibited IICR, whereas SITS inhibited IICR by 74 Ϯ 4% (Fig. 7B) . We conclude that washing away the stilbene derivatives did not reverse the inhibition of IICR. Irreversible binding of stilbene derivatives was also observed for the interaction with the RyR (O'Neill et al., 2003) and may involve isothiocyanate groups on DIDS and SITS.
For suramin, we have previously shown that it decreased the apparent sensitivity of the IP 3 R for IP 3 , presumably by binding to the N-terminal CaM-binding sites of the receptor (Nadif . Therefore, we performed IP 3 -binding experiments to see whether DIDS, SITS, or DNDS interfered in a similar way with the IP 3 R. IP 3 -binding measurements were performed in the presence of 50 M stilbene derivative on microsomes from Sf9 cells expressing IP 3 R1. In contrast with suramin, DIDS, SITS, and DNDS had no effect on IP 3 binding (Fig. 7C) .
Another property of the suramin interaction was the interference with the CaM-binding sites of the IP 3 R. We previously showed that suramin interacted with the two different CaM-binding sites on the IP 3 R1 (Nadif . Pull-down experiments with CaM-Sepharose 4B were performed in the presence of 1 M suramin, DIDS, SITS, or DNDS. Suramin inhibited the binding of IP 3 R1 to the CaMSepharose 4B by 58 Ϯ 5% (Fig. 7D) . In contrast, none of the other tested stilbene reagents showed a significant interference. Higher concentrations of DIDS, SITS, and DNDS (100 M) also did not result in an inhibition of the binding of IP 3 R1 to the beads (data not shown). From this part, we conclude that DIDS and SITS are both potent inhibitors of IICR. Although both compounds are structurally related to suramin, the inhibition of IICR occurs via a different mechanism.
Discussion
The present data clearly show that suramin and disulfonic stilbene derivatives potently induce Ca 2ϩ release from the ER in A7r5 and 16HBE14o-cells (Fig. 1) . The properties of this suramin-induced Ca 2ϩ release closely resemble those of the recently identified novel CICR mechanism (Nadif Kasri et al., 2003) .
Disulfonic stilbene derivatives are known to affect ion channels and transporters by both reversible and nonreversible mechanisms. Kawasaki and Kasai (1989) were the first to report that DIDS and SITS activated RyR1 from rabbit skeletal muscle in SR vesicles and lipid bilayers. They found that these compounds locked RyRs in an open state. Irreversible effects are related to reactive isothiocyanate groups that form covalent bonds with a variety of amino acid residues by reacting with NH 2 groups on lysine residues, OH-groups on serine residues, and aromatic groups on tyrosine and cysteine residues. DIDS has two isothiocyanate groups, whereas SITS has only one and DNDS lacks reactive isothiocyanate groups (Fig. 6A) . It is therefore not surprising that DIDS, but not SITS or DNDS, induced Ca 2ϩ release in A7r5 cells similarly to suramin. An increase in intracellular Ca 2ϩ release by DIDS has also been shown for rat pulmonary artery smooth muscle cells (Cruickshank et al., 2003) . This suggests that such an increase in Ca 2ϩ release by disulfonic stilbene derivatives not only occurs in cultured cells but also in some primary cells.
There are two main families of intracellular Ca 2ϩ -release channels, RyRs and IP 3 Rs. However, there is growing evidence that other, not yet identified, intracellular Ca 2ϩ -release pathways could also play important roles. This was already proposed for the release induced by S1P (Pyne and Pyne, 2000) and NAADP (Genazzani and Galione, 1996) , but the molecular identity of both release channels is largely unknown. Besides the "classic" Ca 2ϩ -release pathways, a poorly understood Ca 2ϩ leak from the ER has also been postulated, but its molecular nature is also still unknown , although it has recently been proposed to be a property of a hyperphosphorylated IP 3 R1 (Oakes et al., 2005) or a ribosome-translocon complex . Our data lend support to the idea that additional intracellular Ca 2ϩ -release pathways may be present in some cell types. We showed evidence that suramin activates a release pathway very similar to a CICR mechanism described previously in A7r5 and 16HBE14o-cells (Nadif Kasri et al., 2003) . Such a CICR mechanism was already found in hepatocytes (Wissing et al., 2002) and pancreatic ␤-cells (Beauvois et al., 2004) .
The exact mechanism by which suramin and DIDS activate Ca 2ϩ release remains largely unknown. We found that CaM plays an important role in the regulation of suramin-induced Ca 2ϩ release. We previously proposed that the CICR mechanism in A7r5 cells was activated upon binding of Ca 2ϩ to CaM. Dissociation or relocalization of CaM would lead to activation of CICR. Because suramin has been shown to interact directly with the CaM-binding sites on the IP 3 R and RyR (Klinger et al., 2001; Papineni et al., 2002; Nadif Kasri et al., 2004) , suramin might induce Ca 2ϩ release by replacing endogenous CaM. However, DIDS, which also stimulates Ca 2ϩ release, does not interact in the same way with CaMbinding sites. Suramin was also shown to interact with ATP- 
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binding sites on purinoceptors (Hoyle et al., 1990) and RyRs (Emmick et al., 1994) . Therefore, it is possible that suramin activates Ca 2ϩ release through direct binding to a regulatory ATP-binding site. This could explain why ATP did not further enhance suramin-induced Ca 2ϩ release. However, when comparing with the RyR, we can expect binding of suramin and DIDS to be more complex. It was demonstrated that suramin exerts a triphasic effect on the open probability of the RyR, indicating the presence of high-, intermediate-and low-affinity suramin-binding sites (Hill et al., 2004) . The most probable mechanism for the activation of Ca 2ϩ release in A7r5 cells could therefore also involve multiple binding sites for suramin and DIDS on an as yet unidentified protein. Some of these interaction sites are supposedly irreversible. Within the time resolution of our experiments, we could observe that CICR was faster than the suramin-induced Ca 2ϩ release (Fig. 2) could act on the same release mechanism and that Ca 2ϩ can also modulate the suramin-induced Ca 2ϩ release. We also found that DIDS and SITS are potent blockers of IICR (Fig. 7) , similar to suramin (Nadif . However, we found that DIDS and SITS act differently on the IP 3 R. Whereas suramin decreased the affinity for IP 3 by binding to CaM-binding sites, neither DIDS nor SITS affected IP 3 binding to IP 3 R1 (Fig. 7C) . Moreover, there was no Ca 2ϩ content of the stores decreased during the efflux (f) and how this Ca 2ϩ content was affected by a 2-min application (arrow) of 100 M suramin (F), 100 M DIDS (Ⅺ), 100 M SITS (E), or 100 M DNDS (‚). A23187 was applied to measure the total releasable Ca 2ϩ (OE). Results represent the means Ϯ S.E.M. for three wells. C, intracellular Ca 2ϩ release by suramin (F) and the stilbene derivatives, DIDS (Ⅺ), SITS (E), and DNDS (‚) was plotted as a function of their concentration. Permeabilized A7r5 cells were loaded during 45 min in 150 nM 45 Ca 2ϩ . Cells were then incubated in efflux medium and after 10 min an increasing concentration of the stilbene derivative were added to the cells for 2 min. A23187 (5 M) was applied to measure the total releasable Ca 2ϩ . Results represent the means Ϯ S.E.M. of three independent experiments each performed in 2-fold. effect on the binding of CaM to the IP 3 R1 (Fig. 7D ). This suggests that DIDS and SITS may interact in a more complex way with IP 3 Rs and that they could inactivate the IP 3 R by irreversible binding. It has also been reported that endogenous sulfonates can play an important role in regulating IICR in cerebellum. An endogenous IP 3 R inhibitor was identified and was found to be a sulfonated compound (Watras et al., 2000) . The presence of an endogenous inhibitor in neuronal tissues may be important for extending the dynamic range of IICR. It is possible that suramin, DIDS, or SITS could work in a similar way on the IP 3 R.
We showed that stilbene derivatives may have activatory or inhibitory effects, depending on which Ca 2ϩ -release mechanism they work on. Therefore, caution must be taken in using these pharmacological reagents to study the properties of the intracellular Ca 2ϩ -release mechanisms. In summary, in this study, we confirmed the presence in A7r5 and 16HBE14o-cells of an as-yet-unidentified intracellular Ca 2ϩ -release pathway that is clearly independent from the IP 3 R and RyR. We have shown here that this pathway can be activated in both cell lines by the pharmacological agents suramin and DIDS. In contrast, the frequently used stilbene derivatives DIDS and SITS were also found to be potent inhibitors of the IP 3 R in the cells. This clearly shows the promiscuous effect of these compounds on different types of Ca 2ϩ channels. 
